Search Results - "Martin de Vidales, C."

Reduced late urinary toxicity with high-dose intensity-modulated radiotherapy using intra-prostate fiducial markers for localized prostate cancer by Zapatero, A., Roch, M., Büchser, D., Castro, P., Fernández-Banda, L., Pozo, G., Liñán, O., Martin de Vidales, C., Cruz-Conde, A., García-Vicente, F.

“…Background/purpose To evaluate the impact of intensity-modulated radiotherapy (IMRT) with intra-prostate fiducial markers image-guided radiotherapy (IGRT) on…”
Get full text

Improved Late Rectal and Urinary Toxicity With High-Dose Intensity Modulated Radiation Therapy Using Intraprostate Fiducial Markers for Localized Prostate Cancer by Zapatero, A, Roch, M, Büchser, D, Castro, P, Banda, L. Fernandez, Pozo, G, Martin de Vidales, C, Conde, A. Cruz, Murillo, M.T, Garcia-Vicente, F

Get full text

Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Report on Late Toxicity from DART 01/05 Randomized Phase III Trial by Zapatero, A, Guerrero, A.D, Maldonado, J, Alvarez, A, Gonzalez San Segundo, C, Cabeza Rodriguez, M.D.L.A, Macias, V, Pedro, A, Casas, F, Boladeras, A, Martin de Vidales, C, Vazquez de la Torre, M.L, Calvo, F.A

Get full text

Positive prostate biopsy following radiotherapy can predict metastasis-free survival in localized prostate cancer by Zapatero, A., Adrados, M., Torres, L., Talaya, M.S., Cruz Conde, A., Martin de Vidales, C., Vega Piris, L., Olivier, C., Murillo, M.T.

“…To determine the impact of post-treatment biopsy results on 10-year metastasis-free survival (MFS), overall survival (OS) and cause-specific survival (CSS) in…”
Get full text

Invasive bladder cancer: A single‐institution experience with bladder‐sparing approach by Zapatero, A., Martín de Vidales, C., Marín, A., Cerezo, L., Arellano, R., Rabadán, M., Pérez‐Torrubia, A.

“…Our objective was to assess the efficacy and safety of a selective bladder‐preserving approach by transurethral resection and sequential chemoradiotherapy in…”
Get full text

The Prognostic Value of Expression of HIF1α, PAK-6, and PSMB4 in Intermediate- and High-Risk Localized Prostate Cancer Patients Treated With Androgen Deprivation and Dose Escalation Radiation Therapy by Zapatero, A, Morente, M, Martin de Vidales, C, Lopez, C, Adrados, M, Nieto, S, Arellano, R, Garcia Vicente, F

Get full text

Randomized Phase 3 Trial of Adjuvant Androgen Deprivation in Combination With High-Dose Conformal Radiation Therapy in Intermediate- and High-Risk Localized Prostate Cancer by Zapatero, A, Guerrero, A, Maldonado, J, Alvarez, A, Gonzalez San Segundo, C, Cabeza Rodriguez, M, Macias, V, Pedro-Olive, A, Casas, F, Boladeras, A, Martin de Vidales, C, Vazquez de la Torre, M, Calvo, F.A

Get full text

Predictors for Late Urinary Toxicity After High-Dose Radiation Therapy for Localized Prostate Cancer by Garcia-Vicente, F, Zapatero, A, Martin de Vidales, C, Rodríguez, G, Leaman, O, Cruz-Conde, A, Bermudez, R, Liñan, O, Pérez, L, Torres, J

Get full text

Ten Years Results with High-dose Radiotherapy and Risk-adapted Androgen Deprivation in Prostate Cancer: How Curable is T3 Disease? by Zapatero, A, Garcia-Vicente, F, Martin de Vidales, C, Fernandez, I, Cruz Conde, A, Martin, M

Get full text

Prognostic value of HIF 1α, PAK-6 and PSMB4 expression in men treated with radiation and androgen deprivation for prostate cancer by Zapatero, A, Morente, M, Lopez, C, Martin de Vidales, C, Adrados, M, Nieto, S, Artiga, M, Arellano, R, Garcia Vicente, F, Herranz, L

Get full text

Anemia en paciente anciano, ¿podemos estar tranquilos? by Martín de Vidales-Hernández, C, Mao-Martín, L, García-Panadés, R, Díaz-Sanchez, J

“…ResumenPresentamos el caso de un paciente de 70 años con un descenso progresivo de hemoglobina en analíticas seriadas. Tras un estudio riguroso se llega a un…”
Get full text

PD-0807 MRI-Guided focal boost to intraprostatic lesion using VMAT in prostate cancer. A Phase II Trial by Zapatero, A., Roch, M., Castro Tejero, P., Büchser, D., Martin de Vidales, C., Gonzalez, S., Rodríguez Carnero, P., Murillo, M.T.

Get full text

4018 POSTER Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy. What can they teach us? by Zapatero, A, Martin de Vidales, C, Couñago, F, Mínguez, R, Arellano, R, Nieto, S, Garcia-Vicente, F

Get full text

OC-0338 Prognostic value of testosterone following androgen deprivation and high-dose radiotherapy in prostate cancer by Zapatero, A., Guerrero, A., Maldonado, X., Alvarez, A., González San Segundo, C., Cabeza Rodríguez, M.A., Martin de Vidales, C., Sole, J.M., Pedro Olivé, A., Casas, F., Boladeras, A., Vázquez de la Torre, M.L., Calvo, F.A.

Get full text

OC-0608 Phase II trial of hypofractionated postoperative radiotherapy in prostate cancer: NCT02192788 by Hervás, A., Zapatero, A., Carballo, A.M., Barrado, M., López-Campos, F., Cano, C., Martin de Vidales, C., Rodríguez, A., Eito, C., Salinas, A., Peleteiro, P., Visus, I., Rodríguez Melcón, I., Vázquez, G., Lazo, A., Couñago, F., Guerrero, L., Otero, A., Vasquez, W.A., Samper, P., Caballero, B., Sancho, G., Pérez, R., Olivera, J., del Rey, A.

Get full text

Positive Prostate Biopsy Following Radiation Therapy Can Predict Metastasis-Free Survival In Localized Prostate Cancer by Zapatero, A., Fernandez Banda, L., Büscher, D., Torres, L., Cruz Conde, A., Martin de Vidales C, C., Adrados, M., Olivier, C., Murillo, M.T.

Get full text

PO-0832: Long-term outcomes following organ preservation treatment for muscle invasive bladder cancer by Büchser, D., Zapatero, A., Rogado, J., Talaya, M., Martin de Vidales, C., Arellano, R., Bocardo, G., Cruz Conde, A., Fernandez, L., Perez, L., Murillo, M.

Get full text

Monitoring of Circulating Tumor Cells in Patients With High-Risk Nonmetastatic Prostate Cancer Treated With Radiation Therapy and Hormones: Preliminary Data of an Observational Prospective Phase 2 Study by Zapatero, A., CaamaNo, A. Gomez, Rodriguez, M. D. L. A. Cabeza, Muinelo-Romay, L., Martin de Vidales C, C., Abalo, A., Castro, A. Carballo, Crespo, P. Calvo, Higuero, P. Peleteiro, Cruz-Conde, A., Olivier, C., Mateos, L. Leon, Murillo, M.T., Piris, L. Vega

Get full text

Pathologic Response and Biochemical Results After High-Dose Conformal Radiotherapy and Two Years of Androgen Deprivation in High-Risk Prostate Cancer by Zapatero, A, García-Vicente, F, Martín de Vidales, C, Ríos, P, Mínguez, R, Rabadan, M, Nieto, S

Get full text

Testoterone kinetics after androgen-deprivation therapy in intermediate and high risk prostate cancer: Results from a randomized trial (DART01/05) by González-san Segundo, C, Zapatero, A, Guerrero, A, Maldonado, X, Álvarez, A, Cabeza, M, Macías, V, Casas, F, Pedro-olivé, A, Boladeras, A, Martín de Vidales, C, Vázquez, M, Calvo, F

Get full text